Do reference-based pricing policies really contain drug costs?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.320, 2001-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pay for performance an ethical way to contain drug costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 570, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Reference-based drug pricing in Canada in need of fine-tuning?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Therapeutic Drug Monitoring: Do the Improved Outcomes Justify the Costs?

By Schumacher G.E. Barr J.T.

Clinical Pharmacokinetics, Vol. 40, Iss. 6, 2001-01 ,pp. : 405-409

Adis International

Access to resources Recommend Favorite

Is Canada's medicines review board really holding down costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Is DM a recipe for containing costs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 271, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite